BELLUS Health Inc. (BLU) Stock
BLU is no longer traded. BELLUS Health was acquired by GSK on June 27, 2023.
Each BLU share was exchanged for $14.75 in cash. Prices on this page are historical; the last trade was June 27, 2023 at $14.74.
See GSK stock →BELLUS Health stock price history
BLU final trading statistics
- Final close
- $14.74
- Final trading day
- Jun 27, 2023
- Market cap at delisting
- $1.87B
- Shares outstanding
- 126.81M
- Final 52-week range
- $6.38 – $14.76
- Avg. volume (final 3 mo.)
- 5,401,274
- All-time high (split-adj.)
- $2865.18 · Apr 2004
- All-time low (split-adj.)
- $0.61 · Jul 2016
- Return since IPO
- -98.9%
- Beta
- -0.28
- Book value / share
- $2.91
- Price / book
- 5.06
BELLUS Health annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $16.0K | -$76.1M | -$0.66 |
| FY2021 | $16.0K | -$71.2M | -$0.90 |
| FY2020 | $15.0K | -$31.8M | -$0.65 |
| FY2019 | $26.8K | -$26.4M | -$0.66 |
| FY2018 | $25.7K | -$6.1M | -$0.27 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About BELLUS Health Inc.
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.
BELLUS Health stock FAQ
What happened to BELLUS Health stock?
BELLUS Health was acquired by GSK on June 27, 2023. Shareholders received $14.75 in cash for each share. BLU stock stopped trading on the Nasdaq, with a final close of $14.74 on June 27, 2023.
What did BELLUS Health shareholders receive?
Each BLU share was converted into $14.75 in cash. The deal was valued at about $2.0 billion.
Is BLU stock still trading?
No. BLU was delisted from the Nasdaq on June 27, 2023 and no longer trades on a U.S. exchange.
What was the last price of BLU stock?
BLU closed at $14.74 on its final trading day, June 27, 2023, for a market value of about $1.87B.
What were BELLUS Health's revenue and earnings in its last full fiscal year?
BELLUS Health reported revenue of $16.0K and net income of -$76.1M in fiscal 2022, its last full year as a public company.
When did BELLUS Health go public?
BELLUS Health Inc. stock began trading on December 29, 2008.